Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA in ASD Patients With 15q11-13 Duplication Syndrome
NCT07079696Phase 2Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in Autism Spectrum Disorder (ASD), dup15q syndrome, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tretinoin
03
Conditions
Autism Spectrum Disorder (ASD)dup15q syndrome
Beyond the preview
Go deeper on NCT07079696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079696.